Table 4.

Case-control studies with odds ratio for patients who had ESRD/CKD and were exposed to GBC agents

ReferenceNo. of NSF CasesNo. of Patients with ESRD and Exposure to GBCOdds Ratio
Broome et al. (4)12 (ESRD 8)25841.3
Collidge et al. (36)14 (12 biopsy-proven)141846.6
Deo et al. (32)338031.5
Othersen et al. (37)458820.6
Marckmann et al. (35)13 (ESRD 8)43032.5